Adenovirus: Current epidemiology and emerging approaches to prevention and treatment

Research output: Contribution to journalArticlepeer-review

87 Scopus citations


Infections caused by adenoviruses are associated with significant morbidity and mortality in both hematopoietic stem cell and solid organ transplant recipients. The risk seems to be highest in allogeneic hematopoietic stem cell transplant recipients as well as heart, lung and small-bowel transplant recipients. Management of these infections may be difficult and includes reduction of immunosuppression whenever possible combined sometimes with antiviral therapy (mainly cidofovir). The currently available antiviral therapy is limited by the need for intravenous administration, potentially significant renal and hematologic toxicities. New emerging therapies such as brincidofovir and transfusion of adenovirus-specific T-lymphocytes may increase the available armamentarium for these potentially life-threatening infections.

Original languageEnglish (US)
Article number416
JournalCurrent Infectious Disease Reports
Issue number8
StatePublished - Aug 2014


  • Adenovirus
  • Bone marrow transplant
  • Hematopoietic stem cell transplant
  • Solid organ transplantation

ASJC Scopus subject areas

  • Infectious Diseases


Dive into the research topics of 'Adenovirus: Current epidemiology and emerging approaches to prevention and treatment'. Together they form a unique fingerprint.

Cite this